NET PROFIT (x1000 EUR)
EMPLOYEES
Pharma-Skan ApS
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
1,978
|
1,875
|
1,564 |
| Total assets |
3,161
|
3,160
|
2,839 |
| Current assets |
3,125
|
3,136
|
2,807 |
| Current liabilities |
471
|
602
|
528 |
| Equity capital |
2,667
|
2,539
|
2,287 |
| - share capital |
27
|
27
|
27 |
| Employees (average) |
15
|
15
|
15 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
84.4%
|
80.3%
|
80.6% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
663.5%
|
520.9%
|
531.6% |
| Return on equity (ROE) |
74.2%
|
73.8%
|
68.4% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.